Stockreport

AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication [Yahoo! Finance]

AstraZeneca PLC - American Depositary Shares  (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF The approval for long-acting C5 complement inhibitor Ultomiris is for the treatment of adult patients with neuromyelitis optica spectrum disorder (NMOSD) who are anti-a [Read more]